Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin
- PMID: 6827150
- DOI: 10.1093/infdis/147.2.352
Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin
Abstract
Vancomycin was used alone and in combination with rifampin in the treatment of experimental osteomyelitis due to Staphylococcus aureus in rabbits. Treatment with 60 mg of vancomycin/kg of body weight twice a day for 28 days was ineffective in sterilizing infected rabbit bones. Rifampin (40 mg/kg) injected once a day for 28 days sterilized 57% of infected rabbit bones. Treatment with a combination of vancomycin and rifampin for either 14 or 28 days was significantly more effective than either drug used alone, sterilizing 84% and 90%, respectively, of the infected bones of treated animals. A possible explanation for the failure of vancomycin when used alone may be that its in vitro activity against the infecting strain of S. aureus (as measured by minimal inhibitory concentrations or minimal bactericidal concentrations) was substantially less under anaerobic conditions (that is, at partial pressures of oxygen analogous to those in osteomyelitic bones) than under aerobic conditions.
Similar articles
-
Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with teicoplanin.Infection. 1986 May-Jun;14(3):136-8. doi: 10.1007/BF01643479. Infection. 1986. PMID: 2942488
-
Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination.Antimicrob Agents Chemother. 1980 Apr;17(4):591-4. doi: 10.1128/AAC.17.4.591. Antimicrob Agents Chemother. 1980. PMID: 7396451 Free PMC article.
-
Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.J Infect Dis. 1985 Jan;151(1):157-65. doi: 10.1093/infdis/151.1.157. J Infect Dis. 1985. PMID: 3965588
-
Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence?Ann Pharmacother. 2013 Jul-Aug;47(7-8):1045-54. doi: 10.1345/aph.1R726. Epub 2013 May 28. Ann Pharmacother. 2013. PMID: 23715070 Review.
-
Rifampin Based Therapy for Patients With Staphylococcus aureus Native Vertebral Osteomyelitis: A Systematic Review and Meta-analysis.Clin Infect Dis. 2024 Jan 25;78(1):40-47. doi: 10.1093/cid/ciad560. Clin Infect Dis. 2024. PMID: 37721158 Free PMC article.
Cited by
-
In vivo antibiotic synergism: contribution of animal models.Antimicrob Agents Chemother. 1992 May;36(5):907-12. doi: 10.1128/AAC.36.5.907. Antimicrob Agents Chemother. 1992. PMID: 1510412 Free PMC article. Review. No abstract available.
-
Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.Antimicrob Agents Chemother. 1989 May;33(5):689-92. doi: 10.1128/AAC.33.5.689. Antimicrob Agents Chemother. 1989. PMID: 2546488 Free PMC article.
-
Reinfection after two-stage revision for periprosthetic infection of total knee arthroplasty.Int Orthop. 2012 Jan;36(1):65-71. doi: 10.1007/s00264-011-1267-x. Epub 2011 May 7. Int Orthop. 2012. PMID: 21553042 Free PMC article.
-
Cefepime clinical pharmacokinetics.Clin Pharmacokinet. 1993 Aug;25(2):88-102. doi: 10.2165/00003088-199325020-00002. Clin Pharmacokinet. 1993. PMID: 8403741 Review.
-
Influence of rifampin therapy on serum bactericidal activity in the presence of cloxacillin and vancomycin.Can J Infect Dis. 1990 Summer;1(2):41-7. doi: 10.1155/1990/357189. Can J Infect Dis. 1990. PMID: 22553438 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical